News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Two top-cited 2023 papers on Annals Of Oncology – ESMO
David Miles and Juan Pascual
Dec 5, 2024, 15:37

Two top-cited 2023 papers on Annals Of Oncology – ESMO

ESMO shared on LinkedIn:

“As Annals Of Oncology 35th Anniversary is commemorated, here are two top-cited 2023 papers:

‘Primary results from IMpassion131: Paclitaxel with or without atezolizumab for triple-negative breast cancer’

Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally advanced/metastatic triple-negative breast cancer

Authors: D. Miles, J. Gligorov, F. André, D. Cameron, A. Schneeweiss, C. Barrios, B. Xu, A. Wardley, D. Kaen, L. Andrade,  V. Semiglazov, M. Reinisch, S. Patel, M. Patre, L. Morales, S.L. Patel, M. Kaul, T. Barata, J. O’Shaughnessy

Annals Of Oncology

‘ESMO recommendations on the use of circulating tumour DNA assays for patients with cancer’

ESMO recommendations on the use of circulating tumour DNA assays for patients with cancer: a report from the ESMO Precision Medicine Working Group

Authors: J. Pascual, G. Attard, F.-C. Bidard, G. Curigliano, L. De Mattos-Arruda, M. Diehn, A. Italiano, J. Lindberg, J.D. Merker, C. Montagut, N. Normanno, K. Pantel, G. Pentheroudakis, S. Popat, J.S. Reis-Filho, J. Tie, J. Seoane, N. Tarazona, T. Yoshino, N.C. Turner

Annals Of Oncology

A. Italiano A. Schneeweiss A. Wardley Annals of Oncology B. Xu C. Barrios C. Montagut cancer D. Cameron D. Kaen D. Miles ESMO F. André F.-C. Bidard G Curigliano G Pentheroudakis G. Attard J. Gligorov J. Lindberg J. O’Shaughnessy J. Pascual J. Seoane J. Tie J.D. Merker J.S. Reis-Filho K. Pantel L. Andrade L. De Mattos-Arruda L. Morales M. Diehn M. Kaul M. Patre M. Reinisch N. Normanno N. Tarazona N.C. Turner OncoDaily Oncology S. Patel S. Popat S.L. Patel T. Barata T. Yoshino V. Semiglazov
Special Coverage
Blog
May 29, 2025, 22:03
Mohamed Elazab Announced “From Early On, You’re Safe” – A Comprehensive Cancer Prevention Campaign in Kafr El-Sheikh
Insight
May 29, 2025, 21:57
European School of Oncology: Apply for Basics in Breast Cancer Surgery course by June 29
Opinion
May 29, 2025, 21:49
Association of European Cancer Leagues Shared a New Position Paper on PFAS free future
Opinion
May 29, 2025, 21:41
To Record or Not to Record – Olumide Ofinran on Patient Requests During Cancer Diagnosis Consultations
Blog
May 29, 2025, 21:35
Toufic Kachaamy: Are the rich, famous and powerful treated differently when it comes to cancer screening?
Career
May 29, 2025, 21:29
Sendurai Mani: Honored to Receive the Master of Arts Degree from Brown University
Blog
May 29, 2025, 21:17
SPCC on Interview with Aleksandra Filipovic and Ellen Langer About Scientifically Proven Connection Between Mindset and Health
Blog
May 29, 2025, 21:09
Sebastian Szmit: Great Pleasure to Work in SERENITY Study by European Commission
Blog
May 29, 2025, 20:53
Jasmine Kamboj Congratulated Jonathan Ticku for FDA ODAC Testimony on Daratumumab
Opinion
May 29, 2025, 20:33
Zainab Shinkafi-Bagudu Reflects on Access, Staffing, and Policy Ahead of AMCE Launch in Nigeria
Blog
May 29, 2025, 19:20
Diego A. Díaz García: sq-NSCLC Data Shows Benmelstobart Plus Chemo as Promising New 1L Option
Positive
May 29, 2025, 19:09
Excited to Announce the 2025 Board of Directors - IASLC